Health
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages – News-Medical.Net
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses…
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The researchers from CureVac AG in Tübingen and the Friedrich-Loeffler-Institute in Greifswald-Insel Riems say that compared with their previous vaccine candidate – CvnCoV – the second-generation CV2CoV vaccine accelerated induction of neutralizing antibody titers…
-
Noosa News20 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News22 hours agoA secret scheme and plans to expel former leaders — here’s what we’ve heard from Queensland’s inquiry into the CFMEU
-
Noosa News21 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 23 November 2025